Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Pfizer |
---|---|
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00139646 |
This is a phase III, multicenter, randomized, single blind study designed to evaluate the efficacy and tolerability of a single dose of parecoxib compared with diclofenac in the treatment of acute pain due to renal colic.
Condition | Intervention | Phase |
---|---|---|
Colic |
Drug: Parecoxib Drug: Diclofenac |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Multicenter Single-Blind, Single Dose Efficacy and Safety Pilot Study Comparing Intramuscular Parecoxib and Diclofenac in Renal Colic |
Estimated Enrollment: | 50 |
Study Start Date: | April 2002 |
Estimated Study Completion Date: | April 2004 |
This study was prematurely discontinued May 3, 2004 due to slow recruitment. The decision to terminate the trial was not based on any safety concerns.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Italy | |
Pfizer Investigational Site | |
Siena, Italy, 53100 | |
Pfizer Investigational Site | |
Alessandria, Italy, 15100 | |
Pfizer Investigational Site | |
Modena, Italy, 41100 | |
Pfizer Investigational Site | |
Grosseto, Italy, 58100 | |
Pfizer Investigational Site | |
Pavia, Italy, 27100 |
Study Director: | Pfizer CT.gov Call Center | Pfizer |
Study ID Numbers: | 124-IFL-0505-005, A3481007 |
Study First Received: | August 29, 2005 |
Last Updated: | May 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00139646 |
Health Authority: | Italy: Ministry of Health |
Signs and Symptoms Parecoxib Signs and Symptoms, Digestive Abdominal Pain |
Colic Diclofenac Pain |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Cyclooxygenase Inhibitors Enzyme Inhibitors Pharmacologic Actions Analgesics, Non-Narcotic |
Sensory System Agents Therapeutic Uses Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |